Bioneer acquires Model Gut Contract Research

The Dynamic Gastric Model expands Bioneer's readily available services for pharmaceutical dosage form testing, drug discovery screening, bioequivalence assessment, and functional food analysis. 

Bioneer has signed an exclusive license agreement with UK technology management company PBL Technology (PBL), regarding use of the Dynamic Gastric Model (DGM) developed at the Institute of Food Research, UK. Bioneer has also acquired PBL's highly successful DGM contract research business (Model Gut) which provides specialist DGM services to the pharmaceutical and food-related industries. The Model Gut services will be integrated into Bioneer's own service offering, under the Bioneer:FARMA brand. The DGM is a breakthrough in the accurate simulation of the human gastric compartment. It is the first truly 'dynamic' in vitro system that fully replicates the complex biochemical conditions, as well as the array of gastric forces crucial for the prediction of the bio-performance of active pharmaceutical ingredients (APIs) and pharmaceutical dosage forms. 

Please click here to read article in full, here for a link to the Dynamic Gastric Model section on our website.

For more information please contact: 
Professor Anette Müllertz, Head of Department, Bioneer:FARMA 
Rebecca McIntosh at PBL